Likely active: portfolio news Mar 2026 Verified 5 Nov 2026
Bramalea Partners
Growth-focused investor partnering with expansion-stage technology companies.
- Type
- VC firm
- Location
- Medfield, Massachusetts, United States
- Stages
- Series B, Growth
- Backs
- B2B software, Biotech and pharma, Medtech and digital health
- Sectors
- Healthtech and life sciences, AI, Fintech, B2B
- Fund size / AUM
- $77.6M Bramalea Partners Fund (Form D offering, 2021); $143.4M gross private fund assets (Form ADV; private funds: 6, of which venture capital: 6)
- Latest fund or filing
- 23 Aug 2022
- Portfolio mix
- B2B software 30%; Biotech and pharma 30%; Medtech and digital health 20%; Hardware 10%; Fintech 10% (n=10)
- Website
- bramaleapartners.com
Contacts on file
For Bramalea Partners, the paid file holds: 2 named decision-makers with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
BellabeatCondorsoftwareDragonflytxHealthiqKindbody
Sources
- www.sec.gov/Archives/edgar/data/1845825/000184582522000001/
- adviserinfo.sec.gov/firm/summary/312893
- www.bramaleapartners.com/
- www.bramaleapartners.com/our-approach
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 55 lists
Growth-stage investors in Massachusetts (18)Fintech investors in Massachusetts (26)Series B B2B investors in the US (27)Series B biotech investors in the US (34)Series B medtech investors in the US (36)Medtech investors in Massachusetts (37)Biotech investors in Massachusetts (37)Growth-stage biotech investors in the US (44)Series B B2B investors (46)Growth-stage B2B investors in the US (54)SaaS investors in Massachusetts (55)Series B medtech investors (57)Healthtech investors in Massachusetts (58)Series B fintech investors in the US (59)AI investors in Massachusetts (61)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Series B biotech investors (73)Growth-stage fintech investors in the US (97)Growth-stage medtech investors (107)Series B SaaS investors in the US (108)Growth-stage biotech investors (109)Growth-stage B2B investors (119)Growth-stage healthtech investors in the US (121)Series B AI investors in the US (126)Series B fintech investors (127)Series B healthtech investors (160)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Series B investors in the US (165)Venture capital firms in Massachusetts (185)Series B SaaS investors (196)Series B AI investors (204)Growth-stage fintech investors (214)B2B venture capital firms in the US (257)Growth-stage investors in the US (288)Growth-stage AI investors (295)Biotech venture capital firms in the US (297)Growth-stage healthtech investors (316)Series B investors (339)Growth-stage SaaS investors (344)Medtech venture capital firms in the US (350)B2B investors (438)Medtech investors (457)Biotech investors (484)Fintech venture capital firms in the US (525)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Fintech investors (846)SaaS venture capital firms in the US (1,049)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)AI investors (1,576)Venture capital firms in the US (2,975)